LASIX Solution for injection or infusion Ref.[50765] Active ingredients: Furosemide

Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Sanofi-aventis Ireland Ltd., T/A SANOFI, Citywest Business Campus, Dublin 24

Product name and form

Lasix 20mg/2ml Solution for Injection or Infusion.

Pharmaceutical Form
Solution for Injection or Infusion. Clear, colourless aqueous solution.

Qualitative and quantitative composition

Furosemide 20mg in 2ml aqueous solution.

For excipients, see 6.1.

Active Ingredient	Description
Furosemide	Furosemide inhibits active chloride transport in the thick ascending limb. Re-absorption of sodium, chloride from the nephron is reduced and a hypotonic or isotonic urine produced. The evidence from many experimental studies suggests that furosemide acts along the entire nephron with the exception of the distal exchange site.

List of Excipients
Water for Injection Sodium hydroxide (E524) Sodium chloride Lasix 20 mg injection contains approximately 0.14 mmol Na⁺ / ml

Pack sizes and marketing

Type I, PhEur glass ampoules in packs of 5 × 2ml glass ampoules.

Marketing authorization holder

Sanofi-aventis Ireland Ltd., T/A SANOFI, Citywest Business Campus, Dublin 24

Marketing authorization dates and numbers

PA 540/52/2

1^st April 1977 / 1^st January 2006

Drugs

Drug	Countries
LASIX	Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Singapore, Turkey, United States, South Africa

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.